Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate CancerSvend O. Freytag, Benjamin Movsas, I. Aref et al.|International Journal of Radiation Oncology*Biology*Physics|2014Cited by 86
1504 RANDOMIZED, CONTROLLED, PHASE 2 TRIAL OF ONCOLYTIC ADENOVIRUS-MEDIATED SUICIDE GENE THERAPY PLUS IMRT VERSUS IMRT ALONE IN NEWLY DIAGNOSED, INTERMEDIATE-RISK PROSTATE CANCERJames O. Peabody, Benjamin Movsas, Svend O. Freytag et al.|The Journal of Urology|2013Cited by 0